Arizonas bioscience efforts continue to grow through an extensive, statewide collaborative network of initiatives. Now, research capabilities are being allied around the state in a new effort to improve medical diagnostics and human health.
The Arizona Proteomics Alliance (AZPA), a statewide consortium, has been formed to advance the emergent science of proteomics, a science whose broad vision is to understand the biological role of the complete set of proteins in the human body, or proteome.
The initiative combines the expertise of nine leading Arizona institutions including Arizona State University (ASU), Banner Health, Barrow Neurological Institute, Carl T. Hayden Veterans Affairs Medical Center, Intrinsic Bioprobes, Inc., Mayo Clinic, Sun Health Research Institute, Translational Genomics Research Institute (TGen) and the University of Arizona (UA).
"This alliance places Arizona in the forefront of proteomics research capabilities and will no doubt have broad impact on biomedical research and personalized medicine," said Jeff Trent, president and scientific director of the Translational Genomics Research Institute (TGen).
AZPA promotes a team approach to solving problems of significant biomedical interest, according to Michael Mobley, administrative director of AZPA and associate director of the Biodesign Institute at ASU. The alliance will advance the role of proteomics research in the understanding of human health and disease by creating a network of scientists who share resources and expertise.
"AZPA facilitates access to technical and intellectual resources that are rarely surpassed within the U.S., and provides the state with a distinct competitive advantage in this field" said Serrine Lau, scientific director of AZPA, director of Southwest Environmental Health Sciences Center at the University of Arizonas College of Pharmacy and a member of UA's BIO5 Institute. "We are pleased that the resources of
Contact: Joe Caspermeyer
Arizona State University